Patents by Inventor Jerome Guyonnet

Jerome Guyonnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and uses thereof for the treatment of heart failure in domestic animals
    Patent number: 12048677
    Abstract: The invention relates to novel veterinary compositions comprising torasemide or a pharmaceutically acceptable salt thereof and administered in domestic animals according to a predetermined dosage for symptomatic treatment of pulmonary edema associated with heart failure.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: July 30, 2024
    Assignee: CEVA SANTE ANIMALE
    Inventors: Beatrice Besche-Barbazanges, Jerome Guyonnet
  • Veterinary composition comprising torasemide for the treatment of pulmonary edema associated with heart failure in domestic animals
    Patent number: 11666587
    Abstract: The invention relates to novel veterinary compositions comprising torasemide or a pharmaceutically acceptable salt thereof and administered in domestic animals according to a predetermined dosage for symptomatic treatment of pulmonary edema associated with heart failure.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: June 6, 2023
    Assignee: CEVA SANTE ANIMALE
    Inventors: Beatrice Besche-Barbazanges, Jerome Guyonnet
  • Antimicrobial composition
    Patent number: 11331289
    Abstract: The present invention relates to a new topical composition comprising niclosamide and/or oxyclozanide and to the use of said composition for the treatment or prevention of pyoderma or dermatitis in non-human mammals.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: May 17, 2022
    Assignees: CEVA SANTE ANIMALE, UNION THERAPEUTICS A/S
    Inventors: Jérôme Guyonnet, Claudine Zemiriline, Pascal Butty
  • HALOGENATED SALICYLANILIDES FOR TREATING THE SYMPTOMS OF DERMATITIS
    Publication number: 20210379085
    Abstract: The present invention relates to halogenated salicylanilides for use in the treatment of dermatitis in a non-human subject, for example canine or feline atopic dermatitis.
    Type: Application
    Filed: November 1, 2019
    Publication date: December 9, 2021
    Inventors: Morten Otto Alexander Sommer, Claudine Zemirline, Pascal Butty, Jérôme Guyonnet
  • Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate
    Patent number: 11116741
    Abstract: The present invention relates to the use of a serotoninergic receptor antagonist, such as sarpogrelate or compositions thereof, for the treatment and/or prevention of heart damages in mammals.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: September 14, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Estelle Ayme-Dietrich, Jérôme Guyonnet, Roland Lawson, Luc Maroteaux, Laurent Monassier
  • ANTIMICROBIAL COMPOSITION
    Publication number: 20200323801
    Abstract: The present invention relates to a new topical composition comprising niclosamide and/or oxyclozanide and to the use of said composition for the treatment or prevention of pyoderma or dermatitis in non-human mammals.
    Type: Application
    Filed: September 14, 2018
    Publication date: October 15, 2020
    Inventors: Jérôme GUYONNET, Claudine ZEMIRILINE, Pascal BUTTY
  • METHOD FOR THE TREATMENT OF HEART DISEASE IN MAMMALS
    Publication number: 20200297685
    Abstract: The present invention relates to the use of a serotoninergic receptor antagonist for the treatment and/or prevention of heart damages in mammals.
    Type: Application
    Filed: April 11, 2018
    Publication date: September 24, 2020
    Inventors: ESTELLE AYME-DIETRICH, JÉRÔME GUYONNET, ROLAND LAWSON, LUC MAROTEAUX, LAURENT MONASSIER
  • COMPOSITIONS AND USES THEREOF FOR THE TREATMENT OF HEART FAILURE IN DOMESTIC ANIMALS
    Publication number: 20200206162
    Abstract: The invention relates to novel veterinary compositions comprising torasemide or a pharmaceutically acceptable salt thereof and administered in domestic animals according to a predetermined dosage for symptomatic treatment of pulmonary edema associated with heart failure.
    Type: Application
    Filed: February 7, 2020
    Publication date: July 2, 2020
    Inventors: Beatrice BESCHE-BARBAZANGES, Jerome GUYONNET
  • COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS
    Publication number: 20200016155
    Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Inventors: Patricia OVAERT, Florence BERNAY, Jerome GUYONNET
  • VETERINARY COMPOSITION COMPRISING TORASEMIDE FOR THE TREATMENT OF PULMONARY EDEMA ASSOCIATED WITH HEART FAILURE IN DOMESTIC ANIMALS
    Publication number: 20180221394
    Abstract: The invention relates to novel veterinary compositions comprising torasemide or a pharmaceutically acceptable salt thereof and administered in domestic animals according to a predetermined dosage for symptomatic treatment of pulmonary edema associated with heart failure.
    Type: Application
    Filed: December 11, 2015
    Publication date: August 9, 2018
    Inventors: Beatrice BESCHE-BARBAZANGES, Jerome GUYONNET
  • Treatments with triazines
    Patent number: 9877969
    Abstract: The invention relates to improved methods for protecting non-human animals with triazine compounds by intramuscular or subcutaneous injection(s). The invention can be used with various triazines, such as toltrazuril, in different non-human animals, such as a porcine, an ovine, a bovine, a canine, a feline, or an avian, for protecting them against infectious diseases, such as protozoan disorders.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: January 30, 2018
    Assignee: CEVA SANTE ANIMALE
    Inventors: Hamadi Karembe, Roman Krejci, Jérôme Guyonnet, Hannelie Cilliers
  • PARENTERAL COMPOSITIONS AND USES THEREOF
    Publication number: 20170304450
    Abstract: The present invention relates to a parenteral composition comprising an antibiotic and a non-steroidal anti-inflammatory agent in solution in a particular solvent. The composition is intended in particular to be injected in a non-human mammal, in particular a farm animal. It also relates to a method for treating disorders connected with a microbial infection in non-human mammals by injecting said composition.
    Type: Application
    Filed: September 9, 2015
    Publication date: October 26, 2017
    Applicant: CEVA SANTE ANIMALE
    Inventors: Florence GUIMBERTEAU, Anne GENETEAU, Jerome GUYONNET
  • COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS
    Publication number: 20160175328
    Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.
    Type: Application
    Filed: January 13, 2016
    Publication date: June 23, 2016
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • TREATMENTS OF COCCIDIOSIS WITH INTRAMUSCULAR TRIAZINE COMPOSITIONS
    Publication number: 20150320756
    Abstract: The present invention relates to compositions and methods for treating coccidiosis in non-human mammals. More particularly, the invention relates to intramuscular compositions and methods for treating coccidiosis with a triazine.
    Type: Application
    Filed: December 6, 2013
    Publication date: November 12, 2015
    Inventors: HAMADI KAREMBE, ROMAN KREJCI, JÉRÔME GUYONNET, HANNELIE CILLIERS
  • NEW TREATMENTS WITH TRIAZINES
    Publication number: 20150313905
    Abstract: The invention also relates to improved methods for protecting non-human animals with triazine compounds by intramuscular or subcutaneous injection(s). The invention can be used with various triazines, such as toltrazuril, in different non-human animals such as a porcine, an ovine, a bovine, a canine, a feline, or an avian, for protecting them against infectious diseases, such as protozoan disorders.
    Type: Application
    Filed: December 6, 2013
    Publication date: November 5, 2015
    Inventors: HAMADI KAREMBE, ROMAN KREJCI, JÉRÔME GUYONNET, HANNELIE CILLIERS
  • COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS
    Publication number: 20100183718
    Abstract: The invention relates to novel compositions including an aldosterone antagonist and administered according to a predetermined dosage for treating heart deficiency in non-human mammals.
    Type: Application
    Filed: June 25, 2008
    Publication date: July 22, 2010
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet
  • COMPOSITIONS AND TREATMENTS OF HEART FAILURE IN NON-HUMAN MAMMAL ANIMALS
    Publication number: 20090270356
    Abstract: The invention relates to new compositions comprising an aldosterone antagonist according to a particular posology for the treatment of heart failure in non-human mammal animals.
    Type: Application
    Filed: April 28, 2009
    Publication date: October 29, 2009
    Applicant: CEVA SANTE ANIMALE SA
    Inventors: Patricia Ovaert, Florence Bernay, Jerome Guyonnet